Grants for businesses in New Jersey
Federal agencies awarded $696 million in 106 grants to businesses in New Jersey from fiscal 2021 to 2025. The largest source was Biomedical Advanced Research and Development Authority (BARDA), Biodefense Medical Countermeasure Development. 770 federal grant opportunities are open or forecast now for businesses.
- New Jersey ranks 19th of the 50 states and DC for federal grants to businesses.
- Grants to businesses made up 0% of all federal grant money to recipients in New Jersey.
- That is 1% of all federal grant money to businesses nationwide.
- Awarded, FY 2021 to 2025$696 million
- Grant awards106
- Open now nationwide770
Federal programs that fund businesses in New Jersey
| Program | Awarded to businesses in New Jersey |
|---|---|
| Biomedical Advanced Research and Development Authority (BARDA), Biodefense Medical Countermeasure Development | $192 million |
| Nuclear Energy Research, Development and Demonstration | $106 million |
| Clean Energy Demonstrations | $75.0 million |
| Clean Ports Program | $55.0 million |
| Rail and Transit Security Grant Program | $54.3 million |
| Public Wireless Supply Chain Innovation Fund Grant Program | $45.0 million |
| Research on Chemical and Biological Defense | $32.9 million |
| Clean School Bus Program | $30.7 million |
| Education Stabilization Fund | $25.5 million |
| USAID Foreign Assistance for Programs Overseas | $13.3 million |
Open federal grants businesses can apply for
- Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
Open Closes November 2, 2026 (2 days left) - Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Open Closes November 2, 2026 (2 days left) - BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Program (COSSUP) Training and Technical Assistance (TTA)
Open Closes November 2, 2026 (2 days left) - OJJDP FY 2026 Internet Crimes Against Children (ICAC) Task Force Program Support
Open Closes November 2, 2026 (2 days left) - Topology
Open Closes November 3, 2026 (3 days left) - Geometric Analysis
Open Closes November 3, 2026 (3 days left) - DoW Reconstructive Transplant, Concept Award
Open Closes November 4, 2026 (4 days left) - DoW Bone Marrow Failure, Idea Development Award
Open Closes November 4, 2026 (4 days left) - DoW Bone Marrow Failure, Investigator-Initiated Research Award
Open Closes November 4, 2026 (4 days left) - DoW Bone Marrow Failure, Resource Development Award
Open Closes November 4, 2026 (4 days left) - DoW Reconstructive Transplant, Investigator-Initiated Research Award
Open Closes November 4, 2026 (4 days left) - Exploring and Enhancing Outdoor and Heritage Tourism in the Chesapeake Bay Watershed
Open Closes November 4, 2026 (4 days left) - Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
Open Closes November 5, 2026 (5 days left) - Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases
Open Closes November 5, 2026 (5 days left) - US Travelers Health Research, Surveillance, Communication, and Outreach Network
Open Closes November 5, 2026 (5 days left) - Request for Information - Gauging Investor Interest in the Development and Commercialization of Subsurface Energy Technologies
Open Closes November 5, 2026 (5 days left) - Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
Open Closes November 6, 2026 (6 days left) - DoW Parkinson’s, Early Investigator Research Award
Open Closes November 6, 2026 (6 days left) - DoW Parkinson’s, Investigator-Initiated Research Award
Open Closes November 6, 2026 (6 days left) - Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
Open Closes November 10, 2026 (10 days left) - Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
Open Closes November 10, 2026 (10 days left) - Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Open Closes November 10, 2026 (10 days left) - Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
Open Closes November 10, 2026 (10 days left) - Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
Open Closes November 10, 2026 (10 days left) - Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
Open Closes November 10, 2026 (10 days left)
See all 770 open grants for businesses